Last reviewed · How we verify

Inoculation in vastus lateralis muscle — Competitive Intelligence Brief

Inoculation in vastus lateralis muscle (Inoculation in vastus lateralis muscle) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Immunology.

marketed Immunology Biologic Live · refreshed every 30 min

Target snapshot

Inoculation in vastus lateralis muscle (Inoculation in vastus lateralis muscle) — Beijing Center for Disease Control and Prevention. This is an intramuscular injection administered to the vastus lateralis muscle, likely a vaccine formulation developed by Beijing CDC.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Inoculation in vastus lateralis muscle TARGET Inoculation in vastus lateralis muscle Beijing Center for Disease Control and Prevention marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Inoculation in vastus lateralis muscle — Competitive Intelligence Brief. https://druglandscape.com/ci/inoculation-in-vastus-lateralis-muscle. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: